Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2008 1
2011 4
2012 1
2013 3
2014 1
2015 2
2016 4
2017 9
2018 11
2019 16
2020 8
2021 11
2022 7
2023 2
2024 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

66 results

Results by year

Filters applied: . Clear all
Page 1
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome.
Schwartz GG, Steg PG, Szarek M, Bhatt DL, Bittner VA, Diaz R, Edelberg JM, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Lecorps G, Mahaffey KW, Moryusef A, Pordy R, Quintero K, Roe MT, Sasiela WJ, Tamby JF, Tricoci P, White HD, Zeiher AM; ODYSSEY OUTCOMES Committees and Investigators. Schwartz GG, et al. N Engl J Med. 2018 Nov 29;379(22):2097-2107. doi: 10.1056/NEJMoa1801174. Epub 2018 Nov 7. N Engl J Med. 2018. PMID: 30403574 Free article. Clinical Trial.
Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk.
Valgimigli M, Frigoli E, Heg D, Tijssen J, Jüni P, Vranckx P, Ozaki Y, Morice MC, Chevalier B, Onuma Y, Windecker S, Tonino PAL, Roffi M, Lesiak M, Mahfoud F, Bartunek J, Hildick-Smith D, Colombo A, Stanković G, Iñiguez A, Schultz C, Kornowski R, Ong PJL, Alasnag M, Rodriguez AE, Moschovitis A, Laanmets P, Donahue M, Leonardi S, Smits PC; MASTER DAPT Investigators. Valgimigli M, et al. N Engl J Med. 2021 Oct 28;385(18):1643-1655. doi: 10.1056/NEJMoa2108749. Epub 2021 Aug 28. N Engl J Med. 2021. PMID: 34449185 Clinical Trial.
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab.
Hagström E, Steg PG, Szarek M, Bhatt DL, Bittner VA, Danchin N, Diaz R, Goodman SG, Harrington RA, Jukema JW, Liberopoulos E, Marx N, McGinniss J, Manvelian G, Pordy R, Scemama M, White HD, Zeiher AM, Schwartz GG; ODYSSEY OUTCOMES Investigators. Hagström E, et al. Circulation. 2022 Aug 30;146(9):657-672. doi: 10.1161/CIRCULATIONAHA.121.057807. Epub 2022 Jun 30. Circulation. 2022. PMID: 35770629 Free PMC article. Clinical Trial.
The Absorb Limits.
Gómez Menchero AE, Camacho Freire SJ, Díaz Fernández JF, Roa Garrido J, León Jiménez J, Cardenal Piris R. Gómez Menchero AE, et al. Among authors: diaz fernandez jf. J Invasive Cardiol. 2016 Oct;28(10):E122-E123. J Invasive Cardiol. 2016. PMID: 27705895 Free article.
Update on interventional cardiology.
de la Torre Hernández JM, Díaz Fernández JF, Sabaté Tenas M, Goicolea Ruigomez J. de la Torre Hernández JM, et al. Among authors: diaz fernandez jf. Rev Esp Cardiol (Engl Ed). 2013 Apr;66(4):282-9. doi: 10.1016/j.rec.2012.10.017. Epub 2013 Jan 24. Rev Esp Cardiol (Engl Ed). 2013. PMID: 24775618 Review.
[Update in interventional cardiology].
de la Torre Hernández JM, Díaz Fernández JF, Tenas MS, Ruigómez JG. de la Torre Hernández JM, et al. Among authors: diaz fernandez jf. Rev Esp Cardiol. 2011;64 Suppl 1:13-9. doi: 10.1016/S0300-8932(11)70003-3. Rev Esp Cardiol. 2011. PMID: 21276486 Free article. Review. Spanish.
Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol.
Schwartz GG, Szarek M, Bittner VA, Diaz R, Goodman SG, Jukema JW, Landmesser U, López-Jaramillo P, Manvelian G, Pordy R, Scemama M, Sinnaeve PR, White HD, Gabriel Steg P; ODYSSEY Outcomes Committees and Investigators. Schwartz GG, et al. J Am Coll Cardiol. 2021 Aug 3;78(5):421-433. doi: 10.1016/j.jacc.2021.04.102. J Am Coll Cardiol. 2021. PMID: 34325831 Free PMC article. Clinical Trial.
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial.
Ray KK, Colhoun HM, Szarek M, Baccara-Dinet M, Bhatt DL, Bittner VA, Budaj AJ, Diaz R, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Loizeau V, Lopes RD, Moryusef A, Murin J, Pordy R, Ristic AD, Roe MT, Tuñón J, White HD, Zeiher AM, Schwartz GG, Steg PG; ODYSSEY OUTCOMES Committees and Investigators. Ray KK, et al. Lancet Diabetes Endocrinol. 2019 Aug;7(8):618-628. doi: 10.1016/S2213-8587(19)30158-5. Epub 2019 Jul 1. Lancet Diabetes Endocrinol. 2019. PMID: 31272931 Free article. Clinical Trial.
[Spontaneous postpartum coronary dissection].
Alcalá López J, Romero Hinojosa JA, González-Gay JM, Díaz Fernández JF, Melgares Moreno R, Ramírez Hernández JA, Azpitarte Almagro J. Alcalá López J, et al. Among authors: diaz fernandez jf. Rev Esp Cardiol. 1998 Oct;51(10):844-6. doi: 10.1016/s0300-8932(98)74829-8. Rev Esp Cardiol. 1998. PMID: 9834635 Free article. Review. Spanish.
Cardiogenic shock code 2023, towards a quality multidisciplinary organization.
Martin-Villen L, Martínez-Sellés M, Diaz-Fernandez JF, Zapata-Fenor L. Martin-Villen L, et al. Among authors: diaz fernandez jf. Med Intensiva (Engl Ed). 2023 Jul;47(7):406-410. doi: 10.1016/j.medine.2023.04.001. Epub 2023 May 10. Med Intensiva (Engl Ed). 2023. PMID: 37173216 No abstract available.
66 results